C 11H 21F 2 O 5 PS2 ,monoclinic, P 121 / c 1(no. 14), a =7.607(2) Å, b =7.711(2) Å, c =26.981(5) Å, =97.19(3)°, V =1570.2 Å 3 ,
Source of material
The title compound has been obtained by hetero Diels-Alder reaction between the diethyl phosphonodifluorodithioacetate and the butadiene followed by cis-dihydroxylation using the modified Sharpless conditions [1] . Single crystals were obtained at room temperature by slow evaporation of ac oncentrated methanol/hexane solution.
Discussion
Due to the importance of carbohydrates in biological systems and their involvement in several diseases, disruption of their biosynthetic pathway by elaboration of glycosyltransferase inhibitors has shown agrowing interest in the drug design discovery [2] . In that field, we have been interested in the synthesis of sulfurcontaining difluoromethylphosphonate glycosides such as the title compound. The cis-dihydroxylation reaction using the modified Sharpless conditions gave amixture of two compounds in 8:2 ratio separable by chromatography. These diastereoisomers 1a and 1b resulted from the position or of the two hydroxyls (figure, top) . By assuming that the less bulky SCH 3 substituent on the anomeric carbon was placed in an axial position, the structure of the major diastereoisomer 1a has been studied by X-ray diffraction to assign the relationship between the hydroxyls and the difluorophosphonate group. The results allowed us to confirm the cis relative configuration of the two hydroxyl groups with the difluoromethylphosphonate group, and to assign a(R , R , S )absolute configuration for the three stereogenic centers (C2, C4 and C5) created during the reaction sequence (figure, bottom). 
